• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway

    2019-08-26 01:09:44GaoLiangZouShiZuoShuangLuRuiHanHuYinYingLuJingYangKaiShengDengYeTingWuMaoMuJuanJuanZhuJingZhangZengBaoFangZhangXianWuXueKeZhaoHaiYangLi
    World Journal of Gastroenterology 2019年30期

    Gao-Liang Zou, Shi Zuo, Shuang Lu, Rui-Han Hu, Yin-Ying Lu, Jing Yang, Kai-Sheng Deng, Ye-Ting Wu,Mao Mu, Juan-Juan Zhu, Jing-Zhang Zeng, Bao-Fang Zhang, Xian Wu, Xue-Ke Zhao, Hai-Yang Li

    Abstract BACKGROUND Liver fibrosis is a refractory disease whose persistence can eventually induce cirrhosis or even liver cancer. Early liver fibrosis is reversible by intervention. As a member of the transforming growth factor-beta (TGF-β) superfamily, bone morphogenetic protein 7 (BMP7) has anti-liver fibrosis functions. However, little is known about BMP7 expression changes and its potential regulatory mechanism as well as the relationship between BMP7 and TGF-β during liver fibrosis. In addition, the mechanism underlying the anti-liver fibrosis function of BMP7 needs to be further explored.AIM To investigate changes in the dynamic expression of BMP7 during liver fibrosis,interactions between BMP7 and TGF-β1, and possible mechanisms underlying the anti-liver fibrosis function of BMP7.METHODS Changes in BMP7 expression during liver fibrosis and the interaction between BMP7 and TGF-β1 in mice were observed. Exogenous BMP7 was used to treat mouse primary hepatic stellate cells (HSCs) to observe its effect on activation,migration, and proliferation of HSCs and explore the possible mechanism Guizhou Medical University.

    Key words: Liver fibrosis; Bone morphogenetic protein; Transforming growth factor;Hepatic stellate cells

    INTRODUCTION

    Liver fibrosis is a pathophysiological process of intrahepatic connective tissue dysplasia. In the clinic, viral hepatitis, alcoholic hepatitis, non-alcoholic fatty liver,and autoimmune diseases can all induce liver injury and further activate the repair process of liver injury to induce fibrosis in the liver. Any liver repair and healing process will induce liver fibrosis. If the long-term injury factors cannot be removed,long-term, persistent fibrosis will progress into cirrhosis and further induce liver cancer. Studies in recent years showed that although late-stage cirrhosis and liver cancer are irreversible, the early liver fibrosis process resulting from liver injury is reversible[1,2]. Using early intervention in liver fibrosis to interfere with liver disease progression is a feasible therapeutic strategy. Therefore, studies targeting liver tissue fibrosis are always a hot spot in liver disease research.

    Liver repair mechanisms activated by liver injury mainly include extracellular matrix (ECM) hyperplasia and remodeling and normal hepatocyte proliferation. ECM hyperplasia and degradation are regulated by matrix metalloproteases (MMPs) and tissue inhibitors of MMPs (TIMPs) together[3]. Hepatic stellate cells (HSCs) play an important role in liver fibrosis. When liver injury factors persist, dormant HSCs are activated. HSCs inhibit MMP activity through TIMPs to cause ECM accumulation and produce large amounts of related cytokines, including vascular endothelial growth factor (VEGF), pro-inflammatory cytokine interleukin-6 (IL-6), and pro-fibrogenic factors such as transforming growth factor-β (TGF-β). Secreted TGF-β can further activate HSCs to cause its differentiation into myofibroblasts, which migrate to the injury site to further express a large amount of type I collagen (Col I) and alphasmooth muscle actin (α-SMA); thus, ECM is replaced by newly produced collagen,eventually resulting in the formation of liver scars[4]. Inhibition of HSC activity such as promotion of their apoptosis or restoration of the dormant status of activated HSCs can exert anti-liver fibrosis functions.

    Molecular pathways that play important roles in liver fibrosis include Wnt, TGF-β,and Alx[5]. As a member of the TGF-β family, TGF-β has diverse molecular functions including regulation of cell proliferation, differentiation, and wound healing, and it plays an important role in the development and progression of liver fibrosis[6]. For example, TGF-β activates Smad3, α-SMA, and Col1a1 to promote collagen fiber accumulation and further cause progression of liver fibrosis[7]. Bone morphogenetic protein-7 (BMP7) is a member of the TGF-β family. Unlike TGF-β, BMP7 inhibits fibrosis. In a carbon tetrachloride (CCl4)-induced liver fibrosis model in rats, BMP7 overexpression in the liver through tail injection inhibited liver fibrosis[8]. In a CCl4-induced liver fibrosis model in mice, oral administration of recombinant BMP7 protein could also inhibit liver fibrosis, which might be associated with affecting the TGF-β-mediated Smad signaling pathway[9]. In a Schistosoma japonicum-infected liver fibrosis model, BMP7 regulated liver fibrosis through the TGF-β-Smad signaling pathway[10]. During the development of liver fibrosis, BMP7 activated Smad1/5/8 to inhibit fibrosis[11,12]. In addition, BMP7 inhibited ColIa1 expression by increasing MMP13 and decreasing TIMP2 expression to further inhibit fibrosis[13]. A series of studies reported that TGF-β1 and BMP7 play important regulatory roles in fibrosis.During liver fibrosis in rats, the ratio of the TGF-β/BMP7 expression levels was associated with epithelial-mesenchymal transition (EMT). Elevation of TGF-β/BMP7 suggested aggravation of liver fibrosis[14]. In retinal pigmented epithelial fibrosis, there was an interaction between BMP7/Smad1/5/8 and TGF-β/Smad3, suggesting that the dynamic balance between BMP7 and TGF-β could determine the outcome of liver fibrosis[15]. In the development and progression of kidney diseases, BMP7 also plays an important role[16]. During renal fibrosis caused by kidney injury, BMP7 had an antifibrosis function[17], and the mechanism might be associated with inhibition of the Akt signaling pathway. Furthermore, BMP7 also inhibited the progression of renal fibrosis through inhibition of Smad3, Col1a1, and α-SMA[18]. In patients with corneal abrasion,ITF2357 attenuated corneal fibrosis through regulation of the TGF-β/BMP7 signaling pathway[19]. In patients with chronic hepatitis B, the blood BMP7 level suggested its anti-fibrosis potential[20].

    The exertion of BMP7 functions has significant tissue specificity and cell specificity[21,22]. In previous research, BMP7 played an important role in repressing hepatic fibrosis. However, the expression mode and potential mechanisms of BMP7 are still unknown, and whether there exists a crosstalk between BMP7 and TGF-β1 remains to be revealed. We hypothesized that the activation of BMP7-pSmad1/5/8 pathway may repress hepatic fibrosis by antagonizing TGFβ1 signaling in CCL4-induced fibrotic mice model. The goal of the current study was to investigate the role of BMP7 in liver fibrosis and its potential mechanisms based on its expression mode. We established a CCl4-induced liver fibrosis model in mice to confirm that with the progression of liver fibrosis, BMP7 expression showed a changing trend of first increasing and then decreasing; in contrast, TGF-β1 expression persistently increased. The mechanism study showed that TGF-β1 inhibited BMP7 expression in a time- and dose-dependent manner within a certain dosage range. In addition, we showed that high doses of BMP7 antagonized the TGF-β1-pSmad3 signaling pathway through the pSmad1/5/8 pathway to inhibit HSC activation and subsequent pro-liver fibrosis processes such as proliferation, migration, and collagen secretion. Our data demonstrate that BMP7 is a vital anti-fibrotic factor, and recombinant BMP7 may serve as a potential therapeutic agent for liver fibrosis.

    MATERIALS AND METHODS

    Reagents and antibodies

    TGF-β1 was obtained from R&D Systems (Minneapolis, MN, United States). The following antibodies were purchased: BMP7 (Biosource, Camarillo, CA, United States), procollagen alpha 1 type 1 (1A1) (Santa Cruz Biotechnology, Santa Cruz, CA),p-Smad3, p-Smad1/5/8, p-P38 (EMD Millipore, Billerica, MA, United States), and glyceraldehyde 3-phosphate dehy-drogenase (GAPDH) (Research Diagnostics,Flanders, NJ, United States). Anti-α-SMA antibody, carbon tetrachloride (CCl4), corn oil, and OptiPrep were purchased from Sigma-Aldrich (St. Louis, MO, United States).BMP7 was purchased from Selleckchem and Fisher Scientific (Waltham, MA, United States). All other chemicals and reagents were purchased from Sigma-Aldrich (St.Louis, MO, United States) and Fisher Scientific (Waltham, MA, United States).

    Generation of a mouse model of liver fibrosis

    All animal interventions were approved by the Institutional Animal Care and Use Committee (IACUC) of Guizhou Medical University. The methods and experiment procedures were carried out in accordance with the relevant guidelines and regulations. Mice (C57BL6, eight to ten weeks old) were housed in standard conditions, and sex matched mice were treated with 2.0 μL/g body weight carbon tetrachloride (CCl4) [1:10 (v/v) dilution with corn oil] or corn oil as control by intraperitoneal (i.p.) injections, three times per week for 4 wk[23]. Mice were challenged with CCl4or corn oil (Control), followed by intraperitoneal injection of BMP7 (100 ng/g, three times per week for 4 wk) or 0.9% saline (Vehicle). Mice were sacrificed at 48 h after the last CCl4injection and tissues were harvested.

    Western blot analysis

    Immunoblotting was performed using 1% NP-40 whole liver tissue lysates or whole cell lysates as described previously[23]. The total proteins were extracted and quantified using Bradford protein quantification kits. Protein samples of 40 g each were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE). The proteins were transferred onto polyvinylidene fluoride (PVDF)membranes and incubated with primary antibodies overnight at 4 °C. On the second day, the signal was developed with an electrochemiluminescence detection kit after incubation with the appropriate secondary antibodies.

    Collagen determination

    Collagen deposition in liver tissue sections (5-10 μm, paraffin embedded tissues) was localized by Masson’s trichrome staining using a commercially available staining kit according to the manufacturer’s instructions (Poly Scientific, Bay Shore, NY, United States). Fibrotic lesional density by area was measured on Masson’s trichrome stained sections and quantified by morphometric methodology.

    Cells and cell culture

    Isolation of primary mouse HSCs was performed by enzymatic digestion and density gradient centrifugation as described previously[24]. Briefly, cells were isolated from the livers by in situ liver perfusion with pronase, liberase, and collagenase followed by density gradient centrifugation. Dispersed cell suspension was filtered and centrifuged at 50 g for 2 min to remove hepatocytes. The remaining cell fraction was washed and resuspended in 11.5% OptiPrep, then gently transferred to the tube containing a bottom of 15% OptiPrep, followed by adding the top layer of PBS. The cell fraction was then centrifuged at 1400 g for 20 min. The HSCs fraction layer was obtained at the interface between the top and intermediate layers. The purity of the HSCs fraction was estimated based on autofluorescence. Purity of HSCs was assessed and estimated by auto-florescence one day after isolation, and was always higher than 97%. Cell viability was also examined and HSCs were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS)and antibiotics as described previously[25]. Cells were starved or treated on day 2 after isolation and the duration of starvation or treatment is described in each figure legend. The duration of the whole experiments was within 5-7 d of isolation of HSCs and the passages were 1-2 (as some experiments were needed to passage cells from regular culture flask to experimental cell culture wells).

    BrdU cell proliferation assay and cell count

    BrdU proliferation assay was performed per manufacturer's protocol (Millipore#2750). Briefly, HSCs were seeded at a density of 2 × 104cells per well in a 96-well plate and treated with BMP7 (100 ng/mL). BrdU was added for the last 16 h of incubation. Cells were then fixed, washed, and incubated with anti-BrdU monoclonal antibody and secondary antibody per the manufacture’s protocol. After washing,TMB peroxidase substrate was added and incubated for 30 min in the dark, followed by addition of stop solution. Incorporated BrdU was measured with a microplate reader at 450 nm (Tecan, Invitrogen). For cell count, HSCs were seeded at a density of 1 × 104cells per well in a 96-well plate and treated with BMP7 (100 ng/mL). Cells were trypsinized and viable cells were stained with trypan blue and counted every 24 h after treatment for 5 d.

    Cell migration assay and wound heal assay

    The wound closure monolayer/scratch motility assay was performed as described previously[25]. Briefly, fibroblasts were plated in serum-free DMEM with 1% bovine serum albumin for 24 h. Mitomycin C was added to inhibit cell proliferation. The monolayer was scratched, and the wound area covered by cell migration over indicated time on digital photomicrograph images was calculated. The migration capabilities of HSCs were assessed using a scratch wound assay. Cells were seeded in 24-well plate and maintained with 5% CO2at 37 °C overnight to form a confluent monolayer. Then, a linear wound of 0.4-0.5 mm in width was generated in the monolayer with a sterile 200 μL plastic pipette tip. Any cellular debris was removed by washing with PBS. Cells were then incubated in the presence or absence of BMP7(100 ng/mL). Wound closure was monitored by collecting digitized images at 0, 12,and 24 h post scratch, respectively.

    Patient enrollment

    The normal and liver fibrosis tissue samples were obtained from patients at the Department of Hepatobiliary Surgery of the Affiliated Hospital of Guizhou Medical University (Guiyang, China). Informed consent in writing was obtained from patients.This study protocol was approved by the Review Committee of the Affiliated Hospital of Guizhou Medical University (No. 20150050).

    Statistical analysis

    Data were analyzed using the Student’s t-test (Sigma Plot, SPSS Inc.) for differences between two groups, and are expressed as the mean ± SE. For comparisons among multiple groups, ANOVA (3-way) was performed, followed by t-test with Bonferronni correction using SAS 9.3 (SAS Institute Inc., Cary, NC, United States). All experiments were repeated at least 3 times. Differences were considered statistically significant at P < 0.05 (aP < 0.05,bP < 0.01).

    RESULTS

    Decreased BMP7 and increased TGF-β1 in CCl4-induced liver fibrotic mice

    Previous studies suggested that BMP7 has anti-fibrosis functions[8]. To explore the potential molecular mechanism underlying the anti-fibrosis function of BMP7, we first established a CCl4-induced liver fibrosis model. Mice received intraperitoneal injections of CCl4and were sacrificed after 4 wk. Livers were removed for Masson’s trichrome staining. The CCl4group exhibited a large area of collagen deposition,whereas the control group rarely had traces of collagen formation. The quantitative analysis results showed that the collagen expression level was 4 times higher in the CCl4group than in the control group (Figure 1A and B). Because TGF-β1 is an important pro-fibrogenic factor[6,12], we examined the expression of BMP7 and TGF-β1 in the liver of mice in the CCl4group and the control group. After CCl4injection, the expression levels of BMP7 and TGF-β1 in the liver were already increased after 2 d.With the persistent increase in TGF-β1 expression, the BMP7 expression level was significantly reduced at week 3, and the reduction was even more evident at week 4(Figure 1C and D), suggesting that TGF-β1 might inhibit BMP7 expression.Furthermore, we examined the expression of Smad family proteins and important proteins in muscle fiber formation, including α-SMA and Col1a1. Compared to the control group, pSmad3 expression in the CCl4group was upregulated and pSmad1/5/8 expression was downregulated, which was consistent with the changing trend of TGF-β1 and BMP7. These results suggested that CCl4treatment activated the TGF-β1-pSmad3 signaling pathway and inhibited the BMP7-pSmad1/5/8 signaling pathway. In addition, the α-SMA and Col I expression levels both significantly increased (Figure 1E and F).

    TGF-β1 inhibits BMP7 in a time- and dose-dependent manner

    In the CCl4-induced liver fibrosis model in mice, the expression of TGF-β1 and BMP7 showed opposite changing trends. With the aggravation of fibrosis, TGF-β1 expression increased and BMP7 expression was downregulated, suggesting that TGFβ1 might regulate BMP7 expression. To investigate the potential regulatory relationship between TGF-β1 and BMP7, in vitro cell experiments were further performed.

    Figure 1 Decreased bone morphogenetic protein 7 and increased transforming growth factor-beta 1 in carbon tetrachloride-induced liver fibrotic mice.Mice were challenged by intraperitoneal injections of carbon tetrachloride (CCl4) or control vehicle (Control, corn oil as the vehicle) as described in Materials and Methods. The severity of liver fibrosis was evaluated by using the measures, including A: Masson’s trichrome staining of fibrotic areas (by collagen deposition, 100×);B: Morphometric analysis of fibrotic lesions in the liver; C: Western blot analysis of expression of BMP7 and TGF-β1. At the indicated time points after CCl4 injection (2 d, 1 wk, 2 wk, 3 wk, and 4 wk), equivalent amount of whole liver detergent lysates were blotted for detecting BMP7 and transforming growth factor-beta 1 (TGF-β1).The level of BMP7 protein expression first rose and then fell, which significantly decreased at 4 wk, while TGF-β1 expression showed a gradual upward trend; D:Trend chart of BMP7 and TGF-β1 protein expression in liver-injured mouse model induced by CCl4. cP < 0.01 or dP < 0.01 compared to time point 0, eP < 0.05 compared to time point 2 wk; E: Western blot analysis of expression of p-Smad3, p-Smad1/5/8, α-SMA, and Col I. At the time point 4 wk, equivalent amount of whole liver detergent lysates were blotted for detecting p-Smad3, p-Smad1/5/8, α-SMA (a marker for myofibroblast differentiation), and Col I. Each lane represents one individual mouse. GAPDH was used as a loading control; and F: Densitometry analysis of the expression of p-Smad3, p-Smad1/5/8, α-SMA, and Col I. Data are pooled and represented as the mean ± SE, n = 8 animals per group. bP < 0.01. BMP7: Bone morphogenetic protein 7; p-Smad3: Phosphorylated Smad3; CCl4:Carbon tetrachloride; TGF-β1: Transforming growth factor-beta 1; Col I: Collagen I; α-SMA: Alpha-smooth muscle actin.

    Mouse HSCs were isolated, starved, and then treated with different doses of TGFβ1. BMP7 expression was then measured. The results showed that when the TGF-β1 concentration reached 1.0 ng/mL, BMP7 expression began to decrease. Under stimulation at higher concentrations (2.0 ng/mL and 5.0 ng/mL), the BMP7 expression level significantly decreased with increasing TGFβ1 doses (Figure 2A and B), suggesting that TGF-β1 could inhibit BMP7 expression in a dose-dependent manner. Was the inhibitory effect of TGF-β1 on BMP7 also time-dependent? BMP7 expression was examined at different time points after HSCs were stimulated with 2 ng/mL TGF-β1. The results showed that inhibition of BMP7 expression by TGF-β1 indeed was time-dependent (Figure 2C and D). Our results suggested that TGF-β1 could inhibit BMP7 expression, and this effect was time- and dose-dependent.

    BMP7 inhibits HSC activation, myofibroblast differentiation, and collagen formation

    Figure 2 Transforming growth factor-beta 1 inhibits bone morphogenetic protein 7 in a time- and dose-dependent manner. A: Western blot analysis of expression of BMP7. Primary mouse HSCs were serum starved for 20 h, treated with TGF-β1 at the indicated dose (ng/mL) for 24 h, and lysed. Equivalent amount of whole cell detergent lysates were blotted with the indicated antibodies for detecting BMP7 and GAPDH. B: Densitometry analysis of BMP7 at the indicated TGF-β1 dose. C: Western blot analysis of expression of BMP7 and α-SMA. Primary mouse HSCs were serum starved for 20 h, treated with TGF-β1 (2 ng/mL) for the indicated time periods (h), and lysed. Equivalent amount of whole cell detergent lysates were blotted with the indicated antibodies. D: Densitometry analysis of the association of BMP7 and α-SMA at the indicated time in response to TGF-β1 stimulation. Data are pooled from at least three independent experiments and represented as the mean ± SE. cP < 0.01 or dP < 0.01 compared to time point 0. BMP7: Bone morphogenetic protein 7; TGF-β: Transforming growth factor-beta; α-SMA: Alpha-smooth muscle actin.

    induced by TGF-β1

    TGF-β1 can activate HSCs to differentiate into myofibroblasts, which express a large amount of Col I and α-SMA; therefore, ECM is replaced by newly produced collagen that eventually results in liver scar formation[4]. To confirm whether the anti-fibrosis function of BMP7 is associated with HSCs, BMP7-regulated HSCs activation experiments were performed. BMP7 expression was upregulated in the early stage of liver fibrosis, suggesting that BMP7 has an anti-fibrosis function. It has been reported that BMP7 could achieve its anti-fibrosis function through inhibition of α-SMA and Col I expression[8]. During treatment with 2 ng/mL TGF-β1, stimulation with different concentrations of BMP7 occurred. The results showed that TGF-β1 inhibited BMP7-pSmad1/5/8 expression through activation of pSmad3 when the BMP7 dose was low,whereas TGF-β1 activated pSmad1/5/8 and inhibited pSmad3 expression when the BMP7 dose reached 100 ng/mL. These results suggested that the anti-fibrosis function of BMP7 might be associated with feedback inhibition of TGF-β1 expression by high doses of BMP7 (Figure 3A-C). Next, HSCs were stimulated with 2 ng/mL TGF-β1 and 100 ng/mL BMP7, and the expression of α-SMA and Col I was detected to measure HSC activation and myofibroblast fiber formation ability, respectively. With BMP7 stimulation alone, the expression levels α-SMA and Col I were low. With TGF-β1 stimulation, α-SMA and Col I expression levels both increased. With stimulation by both, high doses of BMP7 reversed TGF-β1 stimulation-induced upregulation of α-SMA and Col I protein expression (Figure 3D and E). In summary, these results suggested that high doses of BMP7 could inhibit HSC activation and formation of myofibroblast fibers through the pSmad1/5/8 signaling pathway to achieve the antifibrosis function.

    BMP7 inhibits HSC migration and proliferation via promoting Smad1/5/8 and attenuating TGF-β1-Smad signaling

    After activation, HSCs differentiate into myofibroblasts and migrate to the injury site to promote collagen formation and generate fibrotic tissues. Because BMP7 inhibits HSC activation and collagen formation, BMP7 might inhibit migration and proliferation of HSCs. To test this hypothesis, we performed wound healing experiments and cell proliferation experiments to explore the regulatory function of BMP7 on the migration and proliferation of HSCs. Compared to the control group, the BMP7 treatment group exhibited significant inhibition of HSC migration (Figure 4A and B) and proliferation (Figure 4C and D). Next, we further detected changes in related molecular pathways. BMP7 treatment upregulated pSmad1/5/8 expression and inhibited pSmad3 expression. Previous studies reported that p38 plays a positive regulatory role in HSC activation and proliferation[22]. Our results showed that p38 expression was significantly downregulated in the BMP7 treatment group (Figure 4E and F), suggesting that BMP7 might regulate HSC migration and proliferation through inhibition of the p38 signaling pathway.

    Figure 3 Bone morphogenetic protein 7 inhibits hepatic stellate cell activation, myofibroblast differentiation, and collagen formation induced by transforming growth factor-beta 1. A: Western blot analysis of expression of p-Smad3 and p-Smad1/5/8. Serum starved (for 20 h) primary mouse HSCs were treated with transforming growth factor-beta 1 (TGF-β1) (2 ng/mL) followed by exogenous BMP7 at the indicated dose or Vehicle for 24 h, and lysed. Equivalent amount of whole cell detergent lysates were blotted with the indicated antibodies. B and C: Densitometry analysis of the effect of exogenous BMP7 on phosphorylation of Smad3 (p-Smad3) and phosphorylation of Smad1/5/8 (p-Smad1/5/8) at the indicated dose. D: Serum starved (for 20 h) primary mouse HSCs were treated with TGF-β1 (2 ng/mL) followed by exogenous BMP7 (100 ng/mL) or Vehicle for 24 h, and lysed. Equivalent amount of whole cell detergent lysates were blotted with the indicated antibodies. E: Densitometry analysis of the effect of exogenous BMP7 on HSCs myofibroblast differentiation and collagen expression evaluated by alphasmooth muscle actin (α-SMA) and collagen I (Col I) expression (normalized to GAPDH) in panel D. Data are pooled from at least three independent experiments and represented as the mean ± SE. bP < 0.01. BMP7: Bone morphogenetic protein 7; p-Smad3: Phosphorylated Smad3; p-Smad1/5/8: Phosphorylated Smad1/5/8; TGFβ1: Transforming growth factor-beta 1; Col I: Collagen I.

    Exogenous BMP7 ameliorates liver fibrosis in a CCl4-induced mouse model

    In vitro experiment results suggested that BMP7 has anti-fibrosis function. To clarify whether this function is still present in mice, we treated CCl4-induced liver fibrosis mice with BMP7. Mice in the corn oil treatment and the CCl4treatment groups were stimulated with Vehicle and BMP7. Compared to the mice in the model group, the degree of liver fibrosis was significantly attenuated in mice after BMP7 treatment(Figure 5A and B), and α-SMA and Col I expression in liver tissues was significantly decreased (Figure 5C and D), suggesting that BMP7 has the functions of anti-collagen fiber deposition and inhibition of liver fibrosis.

    Figure 4 Bone morphogenetic protein 7 inhibits hepatic stellate cell migration and proliferation via promoting Smad1/5/8 and attenuating TGF-β1-Smad signaling. A: Exogenous BMP7 (100 ng/mL) reduced cell migration in a wound scratch heal assay. The scratch wounds were almost healed in the control but gaps remained in the BMP7 treated cells at 24 h. B: Data are pooled and shown as % of wound area covered by cells over the indicated hours, relative to that of uninfected wild type (WT) fibroblasts in dimethyl sulfoxide (DMSO) medium. C: Cell growth in the presence of BMP7 as measured by direct cell count. D: Cell proliferation measured by BrdU cell proliferation assay in the presence of BMP7. E: Western blot analysis of expression of p-Smad3, p-Smad1/5/8, and p-P38. HSCs were treated as in panel A and lysed at 24 h. Equivalent amount of whole cell detergent lysates were used for detection of phosphorylation of Smad3 (p-Smad3), phosphorylation of Smad1/5/8 (p-Smad1/5/8), and phosphorylation of P38 (p-P38). F: Densitometry analysis of the effect of BMP7 on p-Smad3, p-Smad1/5/8, and p-P38 activation at the indicated condition. Data are pooled from at least three independent experiments and represented as the mean ± SE. bP < 0.01. BMP7: Bone morphogenetic protein 7; p-Smad3: Phosphorylated Smad3; p-Smad1/5/8: Phosphorylated Smad1/5/8; TGF-β1: Transforming growth factor-beta 1; Col I: Collagen I; p-P38: Phosphorylated P38.

    BMP7 expression in human fibrotic liver

    In the CCl4-induced liver fibrosis model in mice, BMP7 showed a changing trend of rising first, followed by decreasing, suggesting that BMP7 has an anti-liver fibrosis function (Figure 1C). Does BMP7 expression in patients with liver fibrosis also present this trend? BMP7 expression levels were detected in liver tissues of patients with liver fibrosis and cirrhosis. Compared to normal individuals, BMP7 expression was upregulated in patients with liver fibrosis and downregulated in patients with cirrhosis (Figure 5E and F). This trend is consistent with that in the mouse model,suggesting that BMP7 in the liver exhibits a compensatory increase to exert its antiliver fibrosis function. When the disease further developed into cirrhosis, BMP7 expression was basically in a state of exhaustion, suggesting that the compensatory anti-fibrosis ability of the body is significantly weakened.

    Figure 5 Exogenous bone morphogenetic protein 7 ameliorates liver fibrosis in carbon tetrachloride-induce mice model and bone morphogenetic protein 7 activation is abnormally changed in patient liver tissues. Mice were challenged with carbon tetrachloride (CCl4) or corn oil (Control), followed by intraperitoneal injection of BMP7 (100 ng/g, three times per week for 4 wk) or 0.9% saline (Vehicle) as described in Materials and Methods. The severity of liver fibrosis was evaluated. A: Masson staining (100 ×). B: Morphometric analysis of fibrotic lesions in liver. C: Western blot analysis of expression of α-SMA and Col I. Equivalent amount of whole liver detergent lysates were blotted with the indicated antibodies. Each lane represents one individual mouse. GAPDH was used as a loading control.D: Densitometry analysis of the effect of BMP7 on myofibroblast differentiation (alpha-smooth muscle actin), extracellular matrix production (collagen I). Data are pooled and represented as the mean ± SE, n = 8 animals per group. bP < 0.01. E: Representative sections of Masson staining (100×) from paraffin-embedded sections of normal, fibrotic, and cirrhotic human liver tissues and Western blot analysis of expression of BMP7. Equivalent amount of whole liver detergent lysates were blotted with the BMP7 antibody. Each lane represents one individual person. GAPDH was used as a loading control. F: Densitometry analysis of BMP7 activation in indicated liver tissues. bP < 0.01. BMP7: Bone morphogenetic protein 7; Col I: Collagen I; α-SMA: Alpha-smooth muscle actin; CCl4: Carbon tetrachloride.

    DISCUSSION

    In this study, we found that negatively regulated by TGFβ1, the specific overexpression of BMP7 in fibrotic liver functions as an anti-fibrotic factor by repressing the expression of Col I and α-SMA, thus reducing the formation of collagens.

    During renal fibrosis, BMP7 inhibits collagen fiber formation through inhibition of pSmad3, Col1a1, and α-SMA[18]. In liver fibrosis, focal adhesion kinase (FAK) could activate HSCs to promote the liver fibrosis process[23]. Are changes in BMP7/TGF-β also present in liver fibrosis? Our study showed that exogenous BMP7 inhibited HSC proliferation and migration through the pSmad1/5/8 signaling pathway to resist liver fibrosis, which is consistent with the results of previous studies showing inhibition of liver fibrosis by adenovirus-mediated BMP7 overexpression in the liver[8,9]. This study showed that exogenous BMP7 antagonized the TGF-β1-pSmad3-mediated pro-fibrosis function through activation of the pSmad1/5/8 signaling pathway. p38-AMPK participated in the processes of cell proliferation and differentiation[22]. Our results suggested that BMP7 inhibited HSC proliferation and differentiation into myofibroblasts through inhibition of p38 expression. Downregulation of the fibrosis markers α-SMA and Col I suggested that fibrosis was inhibited. Our data revealed that BMP7 inhibited myofibroblast secretion of the pro-fibrogenic factors α-SMA and Col I to resist liver fibrosis. In summary, our experiments confirmed that BMP7 antagonized the TGF-β-pSmad3 signaling pathway through activation of pSmad1/5/8 to inhibit the pro-liver fibrosis function caused by HSC activation.

    This study not only used in vivo and in vitro experiments to confirm that the increased BMP7 expression in the liver in the early stage of liver fibrosis lesions mainly played an anti-fibrosis role but also discovered evidence of anti-liver fibrosis by BMP7 in an animal model and patients with liver fibrosis. Our in vitro experiments confirmed that increased BMP7 exerted its anti-fibrosis function through inhibition of HSC activation and collagen formation. In the mouse model, the BMP7 expression level first increased, followed by a decrease with the progression of liver fibrosis. The results of detection of BMP7 expression in samples from patients with liver fibrosis and cirrhosis also showed that its expression exhibited a similar change of increasing first, followed by decreasing. The reduced BMP7 expression level in the late stage was closely associated with the increase in TGF-β1 expression. In a lung fibrosis model,BMP7 inhibited TGF-β1-Smad3-ColI expression[19]. Our data suggested that TGF-β1 could inhibit BMP7 expression and that this regulatory function was time- and dosedependent. When high doses of BMP7 were provided, activated BMP7-pSmad1/5/8 signals could in turn antagonize the pro-collagen formation signals of TGF-β1-pSmad3. The antagonizing effect of BMP7 on TGF-β1 was only present with high concentrations of BMP stimulation. In other words, TGF-β1 inhibited the anti-fibrosis function of low doses of BMP7. Increased doses of BMP7 overcame the inhibitory effect of TGF-β1 and antagonized the pro-fibrosis function of TGF-β1 through activation of downstream pathways.

    In summary, we speculate that TGF-β1 negatively regulates the expression of BMP7, however, the inhibition exists within a certain dosage range. In other words,high doses of BMP7 might antagonize TGF signaling in turn. Although we tried to systemically investigate the anti-fibrosis function of BMP7, this study still has limitations. For example, we elucidated the role of TGF-β1 in the regulation of BMP7 and the function of high doses of BMP7 in antagonizing TGF-β1; however, the molecular mechanism underlying the regulation of BMP7 by TGF-β1 was not further studied. To elucidate the regulatory mode between these two factors, we need to further study the regulatory mechanism between TGF-β1 and BMP7, which is our future study direction.

    This study showed that increased BMP7 expression levels had an anti-fibrosis function during liver fibrosis. With the progression of fibrosis, upregulated TGF-β1 expression inhibited the anti-fibrosis function of BMP7 to cause persistent aggravation of fibrosis into cirrhosis. Our study suggested that BMP7 has an anti-fibrosis function and that recombinant BMP7 could be used as a potential anti-fibrosis drug.

    ARTICLE HIGHLIGHTS

    Research background

    Liver fibrosis is a refractory disease. With disease progression, it can eventually progress into liver cirrhosis or even liver cancer, which severely threatens human health and brings heavy economic burdens. It has been confirmed that early liver fibrosis is reversible after intervention and that bone morphogenetic protein 7 (BMP7) has anti-fibrosis functions. However, the relationship between BMP7 expression and liver fibrosis and the specific mechanism underlying the anti-liver fibrosis function are still not very clear. It is necessary to perform further studies and provide theoretical support for application of exogenous BMP7 in anti-liver fibrosis.

    Research motivation

    The imbalance of the BMP7/transforming growth factor-beta (TGF-β1) ratio plays a very important role in the development and progression of organ fibrosis. It has been reported that BMP7 has an anti-liver fibrosis function. However, the mutual regulatory relationship between BMP7 and TGF-β1 and the mechanism underlying the anti-fibrosis function of BMP7 still require further elucidation. Therefore, observation of the dynamic changes in BMP7 and TGF-β1 during liver fibrosis and investigation of the possible mechanism underlying the anti-liver fibrosis function of BMP7 have positive significance in the further understanding and treatment of liver fibrosis.

    Research objectives

    Changes in BMP7 and TGF-β1 expression in the liver fibrosis process were observed to explore the interaction between these two and further study the possible mechanism underlying the antiliver fibrosis function of BMP7.

    Research methods

    Dynamic changes in BMP7 in the liver fibrosis process in mice and the interactive relationship between BMP7 and TGF-β1 were observed. Mouse primary HSCs were treated with exogenous BMP7 to observe the effect on activation, migration, and proliferation of HSCs and explore the possible mechanism underlying the anti-liver fibrosis function of BMP7. Mice with liver fibrosis were treated with exogenous BMP7 to observe the improvement of liver fibrosis by using Masson’s trichrome staining and detecting the expression of the HSC activation indicator α-SMA and the collagen formation associated protein Col I. Changes in the dynamic expression of BMP7 in liver fibrosis in the human body were further observed.

    Research results

    During liver fibrosis in mice, BMP7 expression first increased, followed by a decrease; the same trend was observed in the human body. This change was accompanied by sustained upregulation of TGF-β1 expression. In vitro experiment results showed that TGF-β1 could inhibit BMP7 expression in a time- and dose-dependent manner. In contrast, high doses of exogenous BMP7 could inhibit TGF-β1-induced activation, migration, and proliferation of HSCs; in addition, this inhibitory effect was associated with upregulation of pSmad1/5/8 and downregulation of pSmad3 and p-P38 protein expression by BMP7. In vivo experiment results showed that exogenous BMP7 improved liver fibrosis in mice.

    Research conclusions

    Our study indicated that BMP7 expression first increased, followed by a decrease, during the liver fibrosis process. This changing trend was associated with inhibition of BMP7 expression by sustained upregulation of TGF-β1 in a time- and dose-dependent manner. High doses of BMP7 exhibited anti-liver fibrosis functions. This function was achieved through inhibition of TGF-β1-induced activation, migration, and proliferation of HSCs. Exogenous BMP7 played an anti-liver fibrosis role that was associated with activating BMP7-pSmad1/5/8 and antagonizing TGF-β1-pSmad3 and p-P38.

    Research perspectives

    Our results further emphasized the anti-liver fibrosis function of BMP7 and exhibited the relationship between dynamic changes of BMP7 and TGF-β1 in the liver fibrosis process, which is helpful for deepening our understanding of the mechanism of liver fibrosis and has guiding significance in the selection of anti-liver fibrosis targets. The investigation of the anti-liver fibrosis mechanism of BMP7 suggested the prospect of application of exogenous BMP7 as an anti-liver fibrosis drug.

    国产探花极品一区二区| 91在线精品国自产拍蜜月| 午夜激情av网站| 午夜福利视频在线观看免费| 久久久国产精品麻豆| 国产精品成人在线| 美女xxoo啪啪120秒动态图| 午夜福利影视在线免费观看| 久久久久久久国产电影| 成人免费观看视频高清| av福利片在线| 美女福利国产在线| 亚洲精品一区蜜桃| 中文字幕人妻丝袜制服| 成人国语在线视频| 女性被躁到高潮视频| 新久久久久国产一级毛片| 人妻一区二区av| 亚洲av中文av极速乱| 精品午夜福利在线看| 嫩草影院入口| 女的被弄到高潮叫床怎么办| 日本欧美视频一区| 极品人妻少妇av视频| 国产激情久久老熟女| 综合色丁香网| 精品一区二区三区视频在线| 国产精品蜜桃在线观看| 在线观看一区二区三区激情| 三上悠亚av全集在线观看| 成年av动漫网址| av黄色大香蕉| 精品亚洲成a人片在线观看| 亚洲精品久久成人aⅴ小说| 国产成人精品福利久久| 人成视频在线观看免费观看| 婷婷色麻豆天堂久久| 中文字幕人妻熟女乱码| 一级,二级,三级黄色视频| 亚洲国产av新网站| 亚洲美女黄色视频免费看| 人体艺术视频欧美日本| 亚洲性久久影院| 亚洲在久久综合| 国产成人精品福利久久| 精品国产一区二区三区久久久樱花| 夫妻性生交免费视频一级片| 日本与韩国留学比较| 欧美性感艳星| 热re99久久精品国产66热6| 日韩成人伦理影院| 最新中文字幕久久久久| 午夜福利影视在线免费观看| 秋霞伦理黄片| 香蕉国产在线看| 两个人看的免费小视频| 亚洲国产成人一精品久久久| 欧美日韩一区二区视频在线观看视频在线| 桃花免费在线播放| 在线 av 中文字幕| 日韩在线高清观看一区二区三区| 男人操女人黄网站| 99久久综合免费| 99久久人妻综合| 国产av精品麻豆| 亚洲一级一片aⅴ在线观看| 最近手机中文字幕大全| 亚洲第一av免费看| 亚洲av中文av极速乱| 久久午夜综合久久蜜桃| 男人舔女人的私密视频| 天堂中文最新版在线下载| 国产一区亚洲一区在线观看| 久久人人爽人人片av| 熟女av电影| 街头女战士在线观看网站| 黄片播放在线免费| 精品亚洲乱码少妇综合久久| 欧美精品一区二区大全| 黄片播放在线免费| 精品亚洲乱码少妇综合久久| 国产免费福利视频在线观看| 午夜久久久在线观看| 9热在线视频观看99| 久久久精品免费免费高清| 久久久亚洲精品成人影院| 激情五月婷婷亚洲| 中文字幕亚洲精品专区| 波野结衣二区三区在线| 十分钟在线观看高清视频www| 最近手机中文字幕大全| 日韩视频在线欧美| 汤姆久久久久久久影院中文字幕| 91精品国产国语对白视频| 高清毛片免费看| 欧美最新免费一区二区三区| 大片电影免费在线观看免费| 啦啦啦啦在线视频资源| 99视频精品全部免费 在线| 我的女老师完整版在线观看| 亚洲人与动物交配视频| 久久久久久久久久成人| 视频区图区小说| 日韩欧美精品免费久久| 久久国产精品男人的天堂亚洲 | 成人国语在线视频| 欧美成人午夜精品| 国产在线免费精品| 2018国产大陆天天弄谢| 国产精品久久久久久精品古装| 成年人免费黄色播放视频| 日韩精品有码人妻一区| 久久国内精品自在自线图片| 午夜视频国产福利| 精品国产乱码久久久久久小说| 嫩草影院入口| av视频免费观看在线观看| 蜜臀久久99精品久久宅男| 天美传媒精品一区二区| 高清毛片免费看| 亚洲第一区二区三区不卡| 久久人人爽人人爽人人片va| 99热全是精品| 99视频精品全部免费 在线| 国产成人精品婷婷| 欧美亚洲日本最大视频资源| 亚洲av电影在线进入| 日韩大片免费观看网站| 久久99热6这里只有精品| 精品酒店卫生间| 美女国产视频在线观看| 精品一区二区三区视频在线| 亚洲欧美成人精品一区二区| 少妇被粗大猛烈的视频| 国产精品嫩草影院av在线观看| 人妻 亚洲 视频| 久久99蜜桃精品久久| 黄色毛片三级朝国网站| 成年动漫av网址| 免费人妻精品一区二区三区视频| 王馨瑶露胸无遮挡在线观看| 欧美变态另类bdsm刘玥| 日本wwww免费看| 老司机亚洲免费影院| 一区二区日韩欧美中文字幕 | 女性被躁到高潮视频| 亚洲欧美成人精品一区二区| 色吧在线观看| 人妻系列 视频| 日韩,欧美,国产一区二区三区| 亚洲国产av影院在线观看| 亚洲四区av| 国产精品不卡视频一区二区| 成人国语在线视频| 性色av一级| 国产白丝娇喘喷水9色精品| 一本色道久久久久久精品综合| 水蜜桃什么品种好| www.av在线官网国产| 桃花免费在线播放| 99久久综合免费| 欧美 日韩 精品 国产| 午夜福利乱码中文字幕| 肉色欧美久久久久久久蜜桃| 99热网站在线观看| av在线播放精品| 天堂俺去俺来也www色官网| 青春草视频在线免费观看| 国产av码专区亚洲av| 国产熟女午夜一区二区三区| 久久国产亚洲av麻豆专区| 久久久国产欧美日韩av| 亚洲精品,欧美精品| 男男h啪啪无遮挡| 巨乳人妻的诱惑在线观看| 久久久亚洲精品成人影院| 亚洲,一卡二卡三卡| 午夜福利视频在线观看免费| 免费观看a级毛片全部| 最后的刺客免费高清国语| 两个人免费观看高清视频| 日本色播在线视频| 美女国产高潮福利片在线看| 欧美日本中文国产一区发布| 亚洲内射少妇av| 美女视频免费永久观看网站| 国产高清不卡午夜福利| 一级a做视频免费观看| 婷婷色av中文字幕| 精品福利永久在线观看| av国产久精品久网站免费入址| 国产日韩欧美在线精品| 日韩精品有码人妻一区| 三级国产精品片| 欧美激情极品国产一区二区三区 | 考比视频在线观看| 精品久久久久久电影网| 成人二区视频| 男的添女的下面高潮视频| av国产精品久久久久影院| 久久久久久久亚洲中文字幕| 亚洲色图 男人天堂 中文字幕 | 色94色欧美一区二区| 精品久久蜜臀av无| 狠狠精品人妻久久久久久综合| 亚洲欧美一区二区三区黑人 | 狠狠精品人妻久久久久久综合| 国产福利在线免费观看视频| 嫩草影院入口| 午夜福利乱码中文字幕| av片东京热男人的天堂| 国产精品蜜桃在线观看| 最新的欧美精品一区二区| 美女内射精品一级片tv| 亚洲国产精品999| 亚洲精品乱久久久久久| 九九爱精品视频在线观看| 纵有疾风起免费观看全集完整版| 嫩草影院入口| 在线精品无人区一区二区三| 一级毛片电影观看| 国产成人精品一,二区| 国产熟女午夜一区二区三区| 日韩一区二区三区影片| 中文天堂在线官网| 最后的刺客免费高清国语| 亚洲国产精品999| 亚洲精品色激情综合| 国产无遮挡羞羞视频在线观看| 肉色欧美久久久久久久蜜桃| 亚洲成人手机| 97超碰精品成人国产| 十分钟在线观看高清视频www| 国产69精品久久久久777片| 欧美xxⅹ黑人| 国产免费一区二区三区四区乱码| 免费大片黄手机在线观看| xxx大片免费视频| av女优亚洲男人天堂| 一级片'在线观看视频| 综合色丁香网| 下体分泌物呈黄色| 精品一品国产午夜福利视频| 永久网站在线| 国产一区亚洲一区在线观看| xxxhd国产人妻xxx| 国产 精品1| 久久久久久久亚洲中文字幕| 欧美最新免费一区二区三区| 啦啦啦在线观看免费高清www| 最近的中文字幕免费完整| 久久久久久久亚洲中文字幕| 22中文网久久字幕| 中文字幕最新亚洲高清| 精品99又大又爽又粗少妇毛片| 女性生殖器流出的白浆| 日产精品乱码卡一卡2卡三| 国产高清国产精品国产三级| 国产精品久久久久久久久免| 日本黄大片高清| 久久ye,这里只有精品| 在线亚洲精品国产二区图片欧美| 女性生殖器流出的白浆| 精品一区二区免费观看| 国产老妇伦熟女老妇高清| 国产精品国产av在线观看| 亚洲av国产av综合av卡| 黄片播放在线免费| 欧美日韩亚洲高清精品| 久久女婷五月综合色啪小说| 少妇的丰满在线观看| 日韩 亚洲 欧美在线| 91精品三级在线观看| 亚洲av.av天堂| 欧美成人午夜精品| 精品国产露脸久久av麻豆| 色吧在线观看| 免费日韩欧美在线观看| 亚洲人成网站在线观看播放| 美女主播在线视频| 精品一区二区三区视频在线| 亚洲精品美女久久久久99蜜臀 | 一边亲一边摸免费视频| 又黄又粗又硬又大视频| 亚洲精品美女久久久久99蜜臀 | 99久久综合免费| 久久精品熟女亚洲av麻豆精品| 久久久亚洲精品成人影院| av卡一久久| 久热久热在线精品观看| 国产精品.久久久| 国产男女内射视频| 亚洲av综合色区一区| 国产av精品麻豆| 91久久精品国产一区二区三区| 亚洲国产精品国产精品| 成人毛片a级毛片在线播放| 欧美另类一区| 国产欧美日韩一区二区三区在线| 日本黄色日本黄色录像| 精品久久国产蜜桃| 中文字幕免费在线视频6| 亚洲一码二码三码区别大吗| 国产精品欧美亚洲77777| 久久久久国产精品人妻一区二区| 欧美人与性动交α欧美软件 | 久久久a久久爽久久v久久| 老司机影院毛片| 国产国拍精品亚洲av在线观看| 麻豆乱淫一区二区| 日韩熟女老妇一区二区性免费视频| 一本—道久久a久久精品蜜桃钙片| 亚洲精品第二区| 九草在线视频观看| 少妇的丰满在线观看| 国产乱来视频区| 女性生殖器流出的白浆| 又粗又硬又长又爽又黄的视频| 国产精品一二三区在线看| 亚洲经典国产精华液单| 国产亚洲欧美精品永久| 国产精品国产三级国产专区5o| 色94色欧美一区二区| 午夜激情久久久久久久| 国产色爽女视频免费观看| 一区二区av电影网| 如何舔出高潮| 久久99蜜桃精品久久| 少妇熟女欧美另类| 国产精品国产三级专区第一集| 一二三四在线观看免费中文在 | 嫩草影院入口| 色网站视频免费| 亚洲成人手机| 欧美日韩综合久久久久久| 午夜福利视频精品| 国产一区二区三区综合在线观看 | 精品国产露脸久久av麻豆| 丝袜美足系列| 美女脱内裤让男人舔精品视频| 亚洲高清免费不卡视频| 99精国产麻豆久久婷婷| 亚洲高清免费不卡视频| 美女脱内裤让男人舔精品视频| 美女内射精品一级片tv| 美女脱内裤让男人舔精品视频| 美女内射精品一级片tv| 99精国产麻豆久久婷婷| 亚洲精品国产av成人精品| 久久久久久久久久人人人人人人| videossex国产| 精品少妇黑人巨大在线播放| 免费大片18禁| 在线天堂中文资源库| xxxhd国产人妻xxx| av有码第一页| 热re99久久国产66热| 久久久久国产网址| 嫩草影院入口| 香蕉丝袜av| 亚洲综合精品二区| 国产成人精品久久久久久| 又黄又粗又硬又大视频| 亚洲av日韩在线播放| 在现免费观看毛片| 日韩人妻精品一区2区三区| 国产 精品1| 国产精品 国内视频| 午夜激情av网站| 一级片免费观看大全| 国产成人aa在线观看| 22中文网久久字幕| 国产乱来视频区| 国产精品偷伦视频观看了| 韩国高清视频一区二区三区| 五月伊人婷婷丁香| 久久精品国产a三级三级三级| 日韩制服骚丝袜av| 又黄又爽又刺激的免费视频.| 99久久中文字幕三级久久日本| 精品亚洲成国产av| 一级片'在线观看视频| 免费人成在线观看视频色| 一边亲一边摸免费视频| 久久久欧美国产精品| 青春草亚洲视频在线观看| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 国产综合精华液| 亚洲精品美女久久久久99蜜臀 | 亚洲一码二码三码区别大吗| 国产成人aa在线观看| 男女边摸边吃奶| 久久人人爽人人片av| 大香蕉久久成人网| 欧美日韩亚洲高清精品| 少妇人妻久久综合中文| 久久国产精品男人的天堂亚洲 | 日韩,欧美,国产一区二区三区| 久久97久久精品| 成人亚洲精品一区在线观看| 国产在视频线精品| 久久久久久久久久久久大奶| 黄网站色视频无遮挡免费观看| 成人手机av| 久久久久久人人人人人| 亚洲av.av天堂| 国产一区有黄有色的免费视频| 国产欧美另类精品又又久久亚洲欧美| 亚洲丝袜综合中文字幕| 国产精品女同一区二区软件| 久久久久久久久久成人| 嫩草影院入口| 男女免费视频国产| 少妇 在线观看| 成人手机av| 晚上一个人看的免费电影| 成人国产麻豆网| 精品99又大又爽又粗少妇毛片| 少妇人妻久久综合中文| 久久狼人影院| 成人18禁高潮啪啪吃奶动态图| 色5月婷婷丁香| 国产av国产精品国产| 久久女婷五月综合色啪小说| 国产精品嫩草影院av在线观看| 一级片免费观看大全| 青春草国产在线视频| 哪个播放器可以免费观看大片| 精品99又大又爽又粗少妇毛片| 色婷婷av一区二区三区视频| 精品视频人人做人人爽| 黄片播放在线免费| 久久女婷五月综合色啪小说| 亚洲精品日本国产第一区| 亚洲激情五月婷婷啪啪| 欧美成人精品欧美一级黄| 国产精品秋霞免费鲁丝片| 一个人免费看片子| 夫妻午夜视频| 91精品三级在线观看| av卡一久久| 免费观看在线日韩| 亚洲欧美一区二区三区国产| 国产一区二区三区av在线| 内地一区二区视频在线| 少妇的丰满在线观看| 日韩欧美一区视频在线观看| 在线观看美女被高潮喷水网站| 性高湖久久久久久久久免费观看| 国产精品久久久久成人av| 22中文网久久字幕| 国产精品久久久久久久久免| 国产 精品1| 亚洲精品视频女| 超碰97精品在线观看| 亚洲av成人精品一二三区| av在线老鸭窝| 在线观看国产h片| 亚洲精品美女久久av网站| 成人无遮挡网站| 日本黄大片高清| 99热全是精品| 精品国产一区二区久久| 巨乳人妻的诱惑在线观看| 久久久精品94久久精品| 国产成人精品福利久久| 亚洲四区av| 亚洲精品久久久久久婷婷小说| 亚洲国产欧美日韩在线播放| 最近最新中文字幕免费大全7| 精品人妻在线不人妻| 国产精品女同一区二区软件| 成人亚洲欧美一区二区av| 亚洲国产精品成人久久小说| 91国产中文字幕| 亚洲av在线观看美女高潮| 欧美精品国产亚洲| 在线精品无人区一区二区三| 一本久久精品| 日产精品乱码卡一卡2卡三| 国产爽快片一区二区三区| 五月玫瑰六月丁香| 伦精品一区二区三区| 久久精品国产综合久久久 | 99热这里只有是精品在线观看| 男女啪啪激烈高潮av片| 亚洲国产色片| 久久人妻熟女aⅴ| 免费观看性生交大片5| 久久亚洲国产成人精品v| 黑人猛操日本美女一级片| 男人添女人高潮全过程视频| 18禁裸乳无遮挡动漫免费视频| 极品少妇高潮喷水抽搐| 精品久久久久久电影网| 久久精品国产a三级三级三级| 精品国产一区二区久久| 狠狠精品人妻久久久久久综合| 日韩中字成人| 久久久久久人人人人人| 观看av在线不卡| 久热久热在线精品观看| 国产 一区精品| 啦啦啦啦在线视频资源| 亚洲美女黄色视频免费看| 成人二区视频| 一区在线观看完整版| 飞空精品影院首页| 五月伊人婷婷丁香| 中文字幕制服av| 精品国产乱码久久久久久小说| 香蕉精品网在线| av福利片在线| 超碰97精品在线观看| 久久99一区二区三区| 黑人欧美特级aaaaaa片| 深夜精品福利| 久久久国产一区二区| 乱人伦中国视频| 日日撸夜夜添| 免费少妇av软件| 丝袜人妻中文字幕| 十八禁高潮呻吟视频| 一级毛片电影观看| 免费av不卡在线播放| 日韩 亚洲 欧美在线| 国产国语露脸激情在线看| 亚洲丝袜综合中文字幕| 91精品国产国语对白视频| 交换朋友夫妻互换小说| 狠狠精品人妻久久久久久综合| 日日撸夜夜添| 人妻一区二区av| 春色校园在线视频观看| 亚洲色图 男人天堂 中文字幕 | 视频区图区小说| 成人午夜精彩视频在线观看| 久久韩国三级中文字幕| 1024视频免费在线观看| av黄色大香蕉| 免费大片18禁| 寂寞人妻少妇视频99o| 国产精品久久久久久久久免| 国产国拍精品亚洲av在线观看| 看免费成人av毛片| 亚洲国产色片| 一区二区三区精品91| 91成人精品电影| 亚洲情色 制服丝袜| 精品熟女少妇av免费看| 飞空精品影院首页| 国产激情久久老熟女| 性高湖久久久久久久久免费观看| 一二三四在线观看免费中文在 | 晚上一个人看的免费电影| 少妇的逼好多水| 日韩熟女老妇一区二区性免费视频| 亚洲欧美一区二区三区国产| 亚洲伊人久久精品综合| 国产毛片在线视频| 免费日韩欧美在线观看| 免费在线观看黄色视频的| av视频免费观看在线观看| videossex国产| 婷婷色麻豆天堂久久| 老女人水多毛片| xxxhd国产人妻xxx| 国产永久视频网站| av黄色大香蕉| 天美传媒精品一区二区| 男的添女的下面高潮视频| av线在线观看网站| 国产日韩一区二区三区精品不卡| 精品熟女少妇av免费看| 纯流量卡能插随身wifi吗| 亚洲一级一片aⅴ在线观看| 人妻 亚洲 视频| xxxhd国产人妻xxx| 国产av精品麻豆| 国产黄色视频一区二区在线观看| 美女主播在线视频| 赤兔流量卡办理| 夜夜骑夜夜射夜夜干| 街头女战士在线观看网站| 亚洲国产看品久久| 丝袜美足系列| 黄片无遮挡物在线观看| 国产免费又黄又爽又色| 日日摸夜夜添夜夜爱| 国产黄色免费在线视频| 一级爰片在线观看| 91精品伊人久久大香线蕉| 蜜臀久久99精品久久宅男| 天天影视国产精品| 男男h啪啪无遮挡| 一区二区三区精品91| 亚洲三级黄色毛片| 大片免费播放器 马上看| 在线观看免费日韩欧美大片| 精品国产一区二区三区四区第35| 91精品伊人久久大香线蕉| 日本与韩国留学比较| 国产淫语在线视频| 国产免费一区二区三区四区乱码| 国产精品无大码| 精品人妻在线不人妻| 婷婷色综合www| 国产欧美日韩综合在线一区二区| 热99久久久久精品小说推荐| 2021少妇久久久久久久久久久| 最新中文字幕久久久久| 国产伦理片在线播放av一区| 久久久久精品性色| 少妇人妻久久综合中文| 欧美日本中文国产一区发布|